Depression is associated with frailty and lower quality of life in haemodialysis recipients, but not with mortality or hospitalization.

depression frailty haemodialysis health-related quality of life hospitalization mortality

Journal

Clinical kidney journal
ISSN: 2048-8505
Titre abrégé: Clin Kidney J
Pays: England
ID NLM: 101579321

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 28 06 2022
entrez: 9 2 2023
pubmed: 10 2 2023
medline: 10 2 2023
Statut: epublish

Résumé

Frailty and depression are highly prevalent in haemodialysis recipients, exhibit a reciprocal relationship, and are associated with increased mortality and hospitalization, and lower quality of life. Despite this, there has been little exploration of the relationship between depression and frailty upon patient outcomes. We aimed to explore the relationship between depression and frailty, and their associations with mortality, hospitalization and quality of life. We performed a prospective cohort study of prevalent haemodialysis recipients linked to national datasets for outcomes including mortality and hospitalization. Depression was assessed using the Patient Health Questionnaire-9 (PHQ-9), frailty using the Clinical Frailty Scale (CFS) and quality of life using the EuroQol 5-Dimension (EQ-5D) Summary Index. A total of 485 prevalent haemodialysis recipients were recruited, with 111 deaths and 1241 hospitalizations during follow-up. CFS was independently associated with mortality [hazard ratio (HR) 1.31; 95% confidence interval (CI) 1.08, 1.59; With the addition of frailty, depression was associated with lower hospital admissions, but poorer quality of life. The relationship between frailty and depression, and their influence on outcomes is complex, requiring further study.

Sections du résumé

Background UNASSIGNED
Frailty and depression are highly prevalent in haemodialysis recipients, exhibit a reciprocal relationship, and are associated with increased mortality and hospitalization, and lower quality of life. Despite this, there has been little exploration of the relationship between depression and frailty upon patient outcomes. We aimed to explore the relationship between depression and frailty, and their associations with mortality, hospitalization and quality of life.
Methods UNASSIGNED
We performed a prospective cohort study of prevalent haemodialysis recipients linked to national datasets for outcomes including mortality and hospitalization. Depression was assessed using the Patient Health Questionnaire-9 (PHQ-9), frailty using the Clinical Frailty Scale (CFS) and quality of life using the EuroQol 5-Dimension (EQ-5D) Summary Index.
Results UNASSIGNED
A total of 485 prevalent haemodialysis recipients were recruited, with 111 deaths and 1241 hospitalizations during follow-up. CFS was independently associated with mortality [hazard ratio (HR) 1.31; 95% confidence interval (CI) 1.08, 1.59;
Conclusions UNASSIGNED
With the addition of frailty, depression was associated with lower hospital admissions, but poorer quality of life. The relationship between frailty and depression, and their influence on outcomes is complex, requiring further study.

Identifiants

pubmed: 36755846
doi: 10.1093/ckj/sfac241
pii: sfac241
pmc: PMC9900564
doi:

Types de publication

Journal Article

Langues

eng

Pagination

342-354

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the ERA.

Références

Can J Kidney Health Dis. 2020 May 02;7:2054358120917780
pubmed: 32426148
CMAJ. 2005 Aug 30;173(5):489-95
pubmed: 16129869
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
Am J Kidney Dis. 2022 Sep;80(3):353-363.e1
pubmed: 35257814
BMC Med. 2018 Jul 20;16(1):112
pubmed: 30025524
Am J Kidney Dis. 2022 Jul;80(1):30-45
pubmed: 34906627
Health Qual Life Outcomes. 2014 Feb 28;12:27
pubmed: 24580960
Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1100-1108
pubmed: 28576906
J Frailty Aging. 2016;5(3):174-9
pubmed: 29240319
Clin Kidney J. 2019 Apr 30;13(1):85-94
pubmed: 32083613
J Am Soc Nephrol. 2009 Jul;20(7):1432-5
pubmed: 19443632
Med Care. 1997 Nov;35(11):1095-108
pubmed: 9366889
Arch Gerontol Geriatr. 2018 Sep - Oct;78:96-100
pubmed: 29936330
Ann Behav Med. 2018 Jan 5;52(1):1-8
pubmed: 28762106
Gen Hosp Psychiatry. 2006 Jul-Aug;28(4):306-12
pubmed: 16814629
Blood Purif. 2017;43(1-3):226-234
pubmed: 28114133
Nephrology (Carlton). 2016 Aug;21(8):639-46
pubmed: 26860073
Ageing Res Rev. 2017 Jul;36:78-87
pubmed: 28366616
Can Geriatr J. 2020 Sep 01;23(3):210-215
pubmed: 32904824
Clin Kidney J. 2021 Jul 16;15(1):145-152
pubmed: 35035945
Nephrol Dial Transplant. 2017 Feb 1;32(2):377-384
pubmed: 28186569
Am J Kidney Dis. 2005 Oct;46(4):642-9
pubmed: 16183419
Am J Kidney Dis. 2005 Nov;46(5):919-24
pubmed: 16253733
J Am Med Dir Assoc. 2013 Jun;14(6):392-7
pubmed: 23764209
Int J Epidemiol. 2006 Aug;35(4):1034-43
pubmed: 16709620
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
BMC Geriatr. 2020 Oct 7;20(1):393
pubmed: 33028215
BMJ. 2010 Mar 19;340:c1066
pubmed: 20304934
Trials. 2018 Aug 24;19(1):457
pubmed: 30143028
Clin J Am Soc Nephrol. 2015 May 7;10(5):832-40
pubmed: 25739851
Hemodial Int. 2019 Apr;23(2):239-246
pubmed: 30821900
Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1594-602
pubmed: 25081360
J Public Health (Oxf). 2012 Mar;34(1):138-48
pubmed: 21795302
Am J Kidney Dis. 2014 Apr;63(4):623-35
pubmed: 24183836
Am J Kidney Dis. 2022 Jul;80(1):7-8
pubmed: 35123829

Auteurs

Benjamin M Anderson (BM)

Department of Nephrology and Transplantation, Queen Elizabeth Hospital, Birmingham, UK.
Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.

Muhammad Qasim (M)

Department of Nephrology and Transplantation, Queen Elizabeth Hospital, Birmingham, UK.
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.

Gonzalo Correa (G)

Department of Nephrology, Hospital del Salvador, Santiago, Chile.

Felicity Evison (F)

Department of Health Informatics, Queen Elizabeth Hospital, Birmingham, UK.

Suzy Gallier (S)

Department of Health Informatics, Queen Elizabeth Hospital, Birmingham, UK.
PIONEER: HDR-UK hub in Acute Care, Edgbaston, Birmingham, UK.

Charles J Ferro (CJ)

Department of Nephrology and Transplantation, Queen Elizabeth Hospital, Birmingham, UK.
Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.

Thomas A Jackson (TA)

Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Department of Healthcare for Older People, Queen Elizabeth Hospital, Birmingham, UK.

Adnan Sharif (A)

Department of Nephrology and Transplantation, Queen Elizabeth Hospital, Birmingham, UK.
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.

Classifications MeSH